The clinical impact of rapid genome sequencing of infants with new-onset epilepsy.
Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024 AAD – Biotech Investments
EQS Newswire / 11/03/2024 / 09:00 UTC+8 Latest data of InnoCare’s ICP-332 for the Treatment of Atopic Dermatitis Presented at LBA Session of 2024